Pfizer (PFE) | Stock Overview & Key Data
Pfizer Performance Comparison
Stock Range
Today's Range
Low: $24.16
High: $24.61
on August 8, 2025
52 Week Range
Low: $20.92
High: $30.43
on April 9, 2025
on October 9, 2024
All-Time High: $61.71 on December 20, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$133.8B
EPS
1.38
P/E Ratio (TTM)
17.05
Forward P/E
8.03
P/B Ratio
1.48
PEG Ratio
8.03
Div. Yield
5.32%
ROE
8.62%
Beta
0.440
Debt to Equity
68.84
Financial Highlights
Profitability
Gross Margin
79.26%
Operating Margin
35.17%
Profit Margin
12.62%
Returns and Earnings
Return on Assets (TTM)
4.79%
Return on Equity (TTM)
8.62%
EBITDA
$23.6B
Net Income (TTM)
$7.9B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$11.02
Quarterly Revenue Growth (YoY)
-7.80%
Quarterly Earnings Growth (YoY)
-4.80%
Dividend Information
Last 12-Month Dividend
$1.27
Current Dividend Yield
5.32%
3-Year Average Dividend Yield
1.27%
3-Year Average Annual Dividend
$1.52
3-Year Total Dividends
$4.55
Ex-Dividend Date
January 24, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Pfizer PFE | 133.78B Large-cap | 4.64% | -4.06% | 7.01% | -4.99% | -7.63% | -13.91% | -50.95% | -31.93% |
| Eli Lilly and LLY | 568.58B Mega-cap | -17.93% | -19.55% | -16.74% | -27.99% | -19.59% | -29.83% | 103.08% | 316.85% |
| Johnson & Johnson JNJ | 410.84B Mega-cap | 3.59% | 11.26% | 11.35% | 12.38% | 20.35% | 7.91% | 4.86% | 16.93% |
| Amgen AMGN | 153.26B Large-cap | -2.91% | -2.95% | 5.95% | -2.23% | 11.17% | -10.61% | 16.06% | 20.26% |
| Gilead Sciences GILD | 137.18B Large-cap | 5.50% | 7.52% | 21.65% | 25.06% | 29.96% | 62.11% | 89.66% | 74.32% |
| Bristol-Myers Squibb BMY | 91.23B Large-cap | 3.89% | -2.32% | -1.98% | -17.25% | -19.09% | -1.63% | -39.18% | -27.23% |
Ownership & Short Interest
Insider Ownership
0.07%
Institutional Ownership
67.60%
Shares Short
99M
Short Ratio
2.53
Short % of Shares Outstanding
1.75%
Average 10-Day Volume
43M
Average 90-Day Volume
40M
Pfizer Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Pfizer would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is PFE's 52-week high and low?
- In the last 52 weeks, Pfizer reached a high of $30.43 (on October 9, 2024) and a low of $20.92 (on April 9, 2025).
- What is the market cap and P/E ratio for PFE?
- Curious about Pfizer's size and valuation? Its market capitalization stands at 133.78B. When it comes to valuation, the P/E ratio (trailing twelve months) is 17.05, and the forward P/E (looking ahead) is 8.03.
- Does PFE pay dividends? If so, what's the yield?
- Yes, Pfizer is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 5.32%, and the company has paid an average of $1.52 per share annually over the past 3 years.
- Who are Pfizer's main competitors or similar companies to consider before investing?
When looking at Pfizer, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Eli Lilly and
LLY568.58B Healthcare Drug Manufacturers - General -29.83% 103.08% Johnson & Johnson
JNJ410.84B Healthcare Drug Manufacturers - General 7.91% 4.86% Amgen
AMGN153.26B Healthcare Drug Manufacturers - General -10.61% 16.06% Gilead Sciences
GILD137.18B Healthcare Drug Manufacturers - General 62.11% 89.66% Bristol-Myers Squibb
BMY91.23B Healthcare Drug Manufacturers - General -1.63% -39.18% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Pfizer Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Pfizer's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 8.62%, the Debt to Equity ratio from the most recent quarter is 68.84, and its Gross Profit Margin stands at 79.26%.
- What is the recent revenue and earnings growth for PFE?
- Looking at Pfizer's growth, its revenue over the trailing twelve months (TTM) was $62B. Compared to the same quarter last year (YoY), quarterly revenue grew by -7.80%, and quarterly earnings saw a YoY growth of -4.80%.
- How much of PFE stock is held by insiders and institutions?
- Wondering who owns Pfizer stock? Company insiders (like executives and directors) hold about 0.07% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 67.60%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.